Elevaris Medical Devices Emerges from the Merger of Spectra Medical and XL Precision Technologies

Elevaris Medical Devices: A New Era in Precision Medical Manufacturing

On January 28, 2025, Spectra Medical Devices and XL Precision Technologies announced their unified brand identity, Elevaris Medical Devices. This merger marks a significant milestone in the medical device industry, creating a world-class Contract Development and Manufacturing Organization (CDMO) specializing in precision medical device solutions.

The union is rooted in a shared legacy of trust and expert experience. With the acquisition of XL Precision Technologies by Spectra, which was announced in September 2024 with the help of QHP Capital, the two companies combined their strengths to serve a wide range of medical device manufacturers, from large-scale Original Equipment Manufacturers (OEMs) to emerging startups. Spectra has long been revered for its comprehensive engineering capabilities and technical support for OEMs, while XLPT has earned accolades for its specialization in manufacturing precision microcomponents and complex tubular assemblies.

The formal announcement of this new name and identity symbolizes an evolution that honors the rich history of each company while highlighting their commitment to delivering unparalleled knowledge, collaborative efforts, and extensive precision manufacturing capabilities worldwide.

Richard Zrebiec, CEO of Elevaris Medical Devices, stated, "The acquisition brought together two trusted companies with highly complementary capabilities. As we complete the integration, operating under a single brand demonstrates our unified commitment to customer success."

As a newly branded entity, Elevaris Medical Devices promises unparalleled services to medical device businesses. The unified team of engineering, design, and development experts is deeply committed to applying their extensive knowledge and product perspectives. They aim to provide value-driven design, development, and production solutions that enhance project success for clients.

Zrebiec remarked, "From concept through design, development, and manufacturing, we are exceptionally qualified to support our clients in developing the next generation of medical devices that will shape the future of healthcare and improve global health." He continued, "Elevaris Medical Devices is poised to become the preferred partner for driving a new era of precision medical device development and manufacturing."

About Elevaris Medical Devices

Elevaris Medical Devices is a Contract Development and Manufacturing Organization (CDMO) serving leading multinational healthcare companies, global OEMs, and emerging technology firms. It is a premier manufacturer of custom procedure needles and specializes in precision microcomponent manufacturing, complex tubular components, and assemblies for the medical device sector. The company also distributes a comprehensive range of pharmaceuticals, surgical instruments, and medical supplies.

With over 300 employees across North America, the UK, and South Korea, Elevaris Medical Devices is committed to elevating the standards of healthcare innovation. For more information, visit elevarismedical.com.

Conclusion

The launch of Elevaris Medical Devices not only signifies the strength of the combined expertise of Spectra and XLPT but also sets the stage for future advancements in the medical device industry. As healthcare technology continues to evolve, Elevaris aims to lead the charge, ensuring high-quality medical solutions are developed to meet the demands of tomorrow's healthcare systems.